New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Enables millions of Indians to monitor their vitals without the need of any additional device
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
The company plans to launch the product immediately
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Subscribe To Our Newsletter & Stay Updated
